These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 9548180)

  • 61. Unexplained elevated maternal serum beta-HCG concentration and adverse pregnancy outcome.
    Ganapathy R; Lamont RF; Bassett P
    Prenat Diagn; 2007 Nov; 27(11):995-9. PubMed ID: 17621365
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The role of unexplained high serum alpha-fetoprotein (AFP) and human chorionic gonadotropin (hCG) levels in the second trimester to determine poor obstetric outcomes.
    Öztürk H; Erkaya S; Altınbaş S; Karadağ B; Vanlı Tonyalı N; Özkan D
    Turk J Obstet Gynecol; 2014 Sep; 11(3):142-147. PubMed ID: 28913007
    [TBL] [Abstract][Full Text] [Related]  

  • 63. First-trimester maternal serum human chorionic gonadotrophin as a marker for fetal chromosomal disorders. The Dutch Working Party on Prenatal Diagnosis.
    Van Lith JM
    Prenat Diagn; 1992 Jun; 12(6):495-504. PubMed ID: 1387477
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Pathologic findings in pregnancies with unexplained increases in midtrimester maternal serum human chorionic gonadotropin levels.
    Liu DF; Dickerman LH; Redline RW
    Am J Clin Pathol; 1999 Feb; 111(2):209-15. PubMed ID: 9930142
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Elevated maternal mid-trimester chorionic gonadotropin > or =4 MoM is associated with fetal cerebral blood flow redistribution.
    Hershkovitz R; Erez O; Sheiner E; Landau D; Mankuta D; Mazor M
    Acta Obstet Gynecol Scand; 2003 Jan; 82(1):22-7. PubMed ID: 12580835
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The association of triple-marker test results with adverse pregnancy outcomes in low-risk pregnancies with healthy newborns.
    Sayin NC; Canda MT; Ahmet N; Arda S; Süt N; Varol FG
    Arch Gynecol Obstet; 2008 Jan; 277(1):47-53. PubMed ID: 17653738
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Second-trimester maternal serum screening for Down's syndrome: free beta-human chorionic gonadotrophin (HCG) and alpha-fetoprotein, with or without unconjugated oestriol, compared with total HCG, alpha-fetoprotein and unconjugated oestriol.
    Extermann P; Bischof P; Marguerat P; Mermillod B
    Hum Reprod; 1998 Jan; 13(1):220-3. PubMed ID: 9512261
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Dimeric inhibin A as a marker for Down's syndrome in early pregnancy.
    Aitken DA; Wallace EM; Crossley JA; Swanston IA; van Pareren Y; van Maarle M; Groome NP; Macri JN; Connor JM
    N Engl J Med; 1996 May; 334(19):1231-6. PubMed ID: 8606718
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Human chorionic gonadotrophin and alpha-fetoprotein levels in matched samples of amniotic fluid, extraembryonic coelomic fluid, and maternal serum in the first trimester of pregnancy.
    Wathen NC; Cass PL; Kitau MJ; Chard T
    Prenat Diagn; 1991 Mar; 11(3):145-51. PubMed ID: 1710066
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The use of ultrasound to detect small-for-gestational-age infants in patients with elevated human chorionic gonadotropin on maternal serum screening.
    Hatfield T; Caughey AB; Lagrew DC; Heintz R; Chung JH
    Am J Perinatol; 2010 Feb; 27(2):173-80. PubMed ID: 19742421
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Decreased serum levels of kisspeptin in early pregnancy are associated with intra-uterine growth restriction and pre-eclampsia.
    Armstrong RA; Reynolds RM; Leask R; Shearing CH; Calder AA; Riley SC
    Prenat Diagn; 2009 Oct; 29(10):982-5. PubMed ID: 19582702
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Increased maternal serum activin A but not follistatin levels in pregnant women with hypertensive disorders.
    D'Antona D; Reis FM; Benedetto C; Evans LW; Groome NP; de Kretser DM; Wallace EM; Petraglia F
    J Endocrinol; 2000 Apr; 165(1):157-62. PubMed ID: 10750046
    [TBL] [Abstract][Full Text] [Related]  

  • 73. First-trimester maternal serum activin A in pre-eclampsia and fetal growth restriction.
    Ong CY; Liao AW; Munim S; Spencer K; Nicolaides KH
    J Matern Fetal Neonatal Med; 2004 Mar; 15(3):176-80. PubMed ID: 15280143
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Elevated second-trimester maternal serum hCG alone or in combination with elevated alpha-fetoprotein.
    Benn PA; Horne D; Briganti S; Rodis JF; Clive JM
    Obstet Gynecol; 1996 Feb; 87(2):217-22. PubMed ID: 8559527
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Second Trimester Biochemical Markers as Possible Predictors of Pathological Placentation: A Retrospective Case-Control Study.
    Berezowsky A; Pardo J; Ben-Zion M; Wiznitzer A; Aviram A
    Fetal Diagn Ther; 2019; 46(3):187-192. PubMed ID: 30726846
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Maternal serum analytes as predictors of IUGR with different degrees of placental vascular dysfunction.
    Roman A; Desai N; Krantz D; Liu HP; Rosner J; Vohra N; Rochelson B
    Prenat Diagn; 2014 Jul; 34(7):692-8. PubMed ID: 24677013
    [TBL] [Abstract][Full Text] [Related]  

  • 77. An association between fetal abdominal wall defects and elevated levels of human chorionic gonadotropin in mid-trimester.
    Schmidt D; Rose E; Greenberg F
    Prenat Diagn; 1993 Jan; 13(1):9-12. PubMed ID: 7680473
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Combined measurement of fetal nuchal translucency, maternal serum free beta-hCG, and pregnancy-associated plasma protein A for first-trimester Down's syndrome screening.
    Tsai MS; Huang YY; Hwa KY; Cheng CC; Lee FK
    J Formos Med Assoc; 2001 May; 100(5):319-25. PubMed ID: 11432311
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Serum markers for Down's syndrome in relation to number of previous births and maternal age.
    Wald NJ; Watt HC
    Prenat Diagn; 1996 Aug; 16(8):699-703. PubMed ID: 8878278
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Human chorionic gonadotropin levels between 16 and 21 weeks of pregnancy and prediction of pre-eclampsia.
    Roiz-Hernández J; de J Cabello-Martínez J; Fernández-Mejía M
    Int J Gynaecol Obstet; 2006 Feb; 92(2):101-5. PubMed ID: 16325185
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.